Showing results (41-50 of 138) with videos related to
Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2010
Tailor-made RNAi knockdown against triplet repeat disease-causing allelesMasaki Takahashi, Shoko Watanabe, Miho Murata, et al.Journal of Neurology|October 28, 2003
Toward identification of susceptibility genes for sporadic Parkinson's diseaseTatsushi Toda, Yoshio Momose, Miho Murata, et al.NMR in Biomedicine|November 15, 2008
Degeneration of dementia with Lewy bodies measured by diffusion tensor imagingMiho Ota, Noriko Sato, Masafumi Ogawa, et al.Neuroscience Research|November 21, 2007
Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formationMasato Asanuma, Ikuko Miyazaki, Francisco J Diaz-Corrales, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 23, 2021
Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled TrialToshinari Odawara, Kazuko Hasegawa, Ritsuko Kajiwara, et al.Annals of Neurology|January 10, 2002
Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphismsYoshio Momose, Miho Murata, Kazuhiro Kobayashi, et al.Patient Preference and Adherence|February 17, 2017
Validation of the Japanese translation of the Dysphagia Handicap IndexChihiro Oda, Toshiyuki Yamamoto, Yutaka Fukumoto, et al.Parkinsonism & Related Disorders|January 27, 2020
Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: A phase 3 randomized clinical trialMiho Murata, Toshinari Odawara, Kazuko Hasegawa, et al.Neuromuscular Disorders : NMD|November 7, 2012
Respiratory dysfunction in patients severely affected by GNE myopathy (distal myopathy with rimmed vacuoles)Madoka Mori-Yoshimura, Yasushi Oya, Yukiko K Hayashi, et al.Rinsho Shinkeigaku = Clinical Neurology|August 5, 2014
[Beneficial effects of 3,4-diaminopyridine in a 26-year-old woman with DOK7 congenital myasthenic syndrome who was originally diagnosed with facioscapulohumeral dystrophy]Atsuko Nishikawa, Madoka Mori-Yoshimura, Tomoko Okamoto, et al.Pageof 14